You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Cervical cancer

Cervical cancer Products

A list of all our products on cervical cancer

Filter

Product type

Product typeGuidanceQuality standards

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHealthTech guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting development

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]
Status:
Awaiting development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
24 February 2026
Expected publication date:
7 May 2026
Pembrolizumab with chemoradiation for untreated high-risk advanced cervical cancer [TSID10690]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC